Login / Signup

Absolute Benefits From Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors.

Michael Patrick Bancks
Published in: Diabetes care (2023)
Keyphrases